Vera Therapeutics Files 8-K on Financials
Ticker: VERA · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1831828
| Field | Detail |
|---|---|
| Company | Vera Therapeutics, INC. (VERA) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
TL;DR
Vera Therapeutics dropped an 8-K on Feb 26, 2025, detailing financial condition and results. Check it for the latest numbers.
AI Summary
Vera Therapeutics, Inc. filed an 8-K on February 26, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Brisbane, California.
Why It Matters
This filing provides an update on Vera Therapeutics' financial health and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting on financial condition and results, not indicating any immediate or significant new risks.
Key Players & Entities
- Vera Therapeutics, Inc. (company) — Registrant
- February 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Brisbane, California (location) — Principal executive offices
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these results are not provided in the provided text.
When was this 8-K filing submitted?
The filing was submitted on February 26, 2025.
What is Vera Therapeutics, Inc.'s primary business sector?
Vera Therapeutics, Inc. is in the 'PHARMACEUTICAL PREPARATIONS' sector, with SIC code 2834.
Where are Vera Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 2000 Sierra Point Parkway, Suite 1200, Brisbane, California, 94005.
What is the Commission File Number for Vera Therapeutics, Inc.?
The Commission File Number for Vera Therapeutics, Inc. is 001-40407.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding Vera Therapeutics, Inc. (VERA).